Chemical chronobiology: Toward drugs manipulating time

FEBS Letters

Volumn 589, Issue 14, 2015, Pages 1530-1538

  Wallach, Thomas ^a   Kramer, Achim ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Chemical biology; Circadian rhythm; High throughput screening; Small molecule compound

Indexed keywords

CELL NUCLEUS RECEPTOR; CHEMICAL COMPOUND; PROTEIN KINASE;

BINDING AFFINITY; BINDING SITE; BIOLUMINESCENCE; CIRCADIAN RHYTHM; ENZYME ASSAY; HIGH THROUGHPUT SCREENING; HUMAN; MAMMAL CELL; MOLECULAR DYNAMICS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROCESS OPTIMIZATION; PROTEIN BINDING; PROTEIN DETERMINATION; REVIEW; SIGNAL TRANSDUCTION; STRUCTURE ANALYSIS; ANIMAL; DRUG EFFECTS; PHYSIOLOGY;

MAMMALIA;

ANIMALS; CIRCADIAN CLOCKS; HIGH-THROUGHPUT SCREENING ASSAYS;

EID: 84930272332     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2015.04.059     Document Type: Review

References (100)

1. S.M. Reppert, and D.R. Weaver Coordination of circadian timing in mammals Nature 418 2002 935 941
2. E.E. Zhang, and S.A. Kay Clocks not winding down: unravelling circadian networks Nat. Rev. Mol. Cell Biol. 11 2010 764 776
3. C.L. Partch, C.B. Green, and J.S. Takahashi Molecular architecture of the mammalian circadian clock Trends Cell Biol. 24 2014 90 99
4. M.E. Hughes, L. DiTacchio, K.R. Hayes, C. Vollmers, S. Pulivarthy, J.E. Baggs, S. Panda, and J.B. Hogenesch Harmonics of circadian gene transcription in mammals PLoS Genet. 5 2009 e1000442
5. R. Zhang, N.F. Lahens, H.I. Ballance, M.E. Hughes, and J.B. Hogenesch A circadian gene expression atlas in mammals: implications for biology and medicine Proc. Natl. Acad. Sci. USA 111 2014 16219 16224
6. M. Keller, J. Mazuch, U. Abraham, G.D. Eom, E.D. Herzog, H.D. Volk, A. Kramer, and B. Maier A circadian clock in macrophages controls inflammatory immune responses Proc. Natl. Acad. Sci. USA 106 2009 21407 21412
7. M.S. Robles, J. Cox, and M. Mann In-vivo quantitative proteomics reveals a key contribution of post-transcriptional mechanisms to the circadian regulation of liver metabolism PLoS Genet. 10 2014 e1004047
8. A.B. Reddy et al. Circadian orchestration of the hepatic proteome Curr. Biol. 16 2006 1107 1115
9. D. Mauvoisin et al. Circadian clock-dependent and -independent rhythmic proteomes implement distinct diurnal functions in mouse liver Proc. Natl. Acad. Sci. USA 111 2014 167 172
10. C.K. Chiang et al. The proteomic landscape of the suprachiasmatic nucleus clock reveals large-scale coordination of key biological processes PLoS Genet. 10 2014 e1004695
11. D.P. King et al. Positional cloning of the mouse circadian clock gene Cell 89 1997 641 653
12. B. Maier, S. Wendt, J.T. Vanselow, T. Wallach, S. Reischl, S. Oehmke, A. Schlosser, and A. Kramer A large-scale functional RNAi screen reveals a role for CK2 in the mammalian circadian clock Genes Dev. 23 2009 708 718
13. E.E. Zhang et al. A genome-wide RNAi screen for modifiers of the circadian clock in human cells Cell 139 2009 199 210
14. D.A. Bechtold, J.E. Gibbs, and A.S. Loudon Circadian dysfunction in disease Trends Pharmacol. Sci. 31 2010 191 198
15. J.S. Takahashi, H.K. Hong, C.H. Ko, and E.L. McDearmon The genetics of mammalian circadian order and disorder: implications for physiology and disease Nat. Rev. Genet. 9 2008 764 775
16. E.S. Maywood, J. O'Neill, G.K. Wong, A.B. Reddy, and M.H. Hastings Circadian timing in health and disease Prog. Brain Res. 153 2006 253 269
17. R.V. Kondratov, A.A. Kondratova, V.Y. Gorbacheva, O.V. Vykhovanets, and M.P. Antoch Early aging and age-related pathologies in mice deficient in BMAL1, the core component of the circadian clock Genes Dev. 20 2006 1868 1873
18. F.W. Turek et al. Obesity and metabolic syndrome in circadian Clock mutant mice Science 308 2005 1043 1045
19. L. Fu, H. Pelicano, J. Liu, P. Huang, and C. Lee The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo Cell 111 2002 41 50
20. Y. Xu et al. Functional consequences of a CKIdelta mutation causing familial advanced sleep phase syndrome Nature 434 2005 640 644
21. T. Ebisawa et al. Association of structural polymorphisms in the human period3 gene with delayed sleep phase syndrome EMBO Rep. 2 2001 342 346
22. A. Takano et al. A missense variation in human casein kinase I epsilon gene that induces functional alteration and shows an inverse association with circadian rhythm sleep disorders Neuropsychopharmacology 29 2004 1901 1909
23. K.L. Toh, C.R. Jones, Y. He, E.J. Eide, W.A. Hinz, D.M. Virshup, L.J. Ptacek, and Y.H. Fu An hPer2 phosphorylation site mutation in familial advanced sleep phase syndrome Science 291 2001 1040 1043
24. M.P. Antoch, and M.V. Chernov Pharmacological modulators of the circadian clock as potential therapeutic drugs Mutat. Res. 680 2009 109 115
25. Z. Chen, S.H. Yoo, and J.S. Takahashi Small molecule modifiers of circadian clocks Cell. Mol. Life Sci. 70 2013 2985 2998
26. M.P. Antoch, and R.V. Kondratov Pharmacological modulators of the circadian clock as potential therapeutic drugs: focus on genotoxic/anticancer therapy Handb. Exp. Pharmacol. 2013 289 309
27. E. Ortiz-Tudela, A. Mteyrek, A. Ballesta, P.F. Innominato, and F. Levi Cancer chronotherapeutics: experimental, theoretical, and clinical aspects Handb. Exp. Pharmacol. 2013 261 288
28. M. Gallego, and D.M. Virshup Post-translational modifications regulate the ticking of the circadian clock Nat. Rev. Mol. Cell Biol. 8 2007 139 148
29. S. Reischl, and A. Kramer Kinases and phosphatases in the mammalian circadian clock FEBS Lett. 585 2011 1393 1399
30. K.A. Lamia et al. AMPK regulates the circadian clock by cryptochrome phosphorylation and degradation Science 326 2009 437 440
31. S. Reischl, K. Vanselow, P.O. Westermark, N. Thierfelder, B. Maier, H. Herzel, and A. Kramer Beta-TrCP1-mediated degradation of PERIOD2 is essential for circadian dynamics J. Biol. Rhythms 22 2007 375 386
32. A. Hirano et al. FBXL21 regulates oscillation of the circadian clock through ubiquitination and stabilization of cryptochromes Cell 152 2013 1106 1118
33. L. Busino, F. Bassermann, A. Maiolica, C. Lee, P.M. Nolan, S.I. Godinho, G.F. Draetta, and M. Pagano SCFFbxl3 controls the oscillation of the circadian clock by directing the degradation of cryptochrome proteins Science 316 2007 900 904
34. S.M. Siepka, S.H. Yoo, J. Park, W. Song, V. Kumar, Y. Hu, C. Lee, and J.S. Takahashi Circadian mutant overtime reveals F-box protein FBXL3 regulation of cryptochrome and period gene expression Cell 129 2007 1011 1023
35. S.H. Yoo et al. Competing E3 ubiquitin ligases govern circadian periodicity by degradation of CRY in nucleus and cytoplasm Cell 152 2013 1091 1105
36. L.F. Larrondo, C. Olivares-Yanez, C.L. Baker, J.J. Loros, and J.C. Dunlap Circadian rhythms. Decoupling circadian clock protein turnover from circadian period determination Science 347 2015 1257277
37. A. Kramer Circadian rhythms. When the circadian clock becomes blind Science 347 2015 476 477
38. T. Wallach, K. Schellenberg, B. Maier, R.K. Kalathur, P. Porras, E.E. Wanker, M.E. Futschik, and A. Kramer Dynamic circadian protein-protein interaction networks predict temporal organization of cellular functions PLoS Genet. 9 2013 e1003398
39. I. Schmutz, S. Wendt, A. Schnell, A. Kramer, I.M. Mansuy, and U. Albrecht Protein phosphatase 1 (PP1) is a post-translational regulator of the mammalian circadian clock PLoS One 6 2011 e21325
40. M. Gallego, H. Kang, and D.M. Virshup Protein phosphatase 1 regulates the stability of the circadian protein PER2 Biochem. J. 399 2006 169 175
41. C.L. Partch, K.F. Shields, C.L. Thompson, C.P. Selby, and A. Sancar Posttranslational regulation of the mammalian circadian clock by cryptochrome and protein phosphatase 5 Proc. Natl. Acad. Sci. USA 103 2006 10467 10472
42. L. Aguilar-Arnal, and P. Sassone-Corsi Chromatin landscape and circadian dynamics: spatial and temporal organization of clock transcription Proc. Natl. Acad. Sci. USA 2014
43. K. Eckel-Mahan, and P. Sassone-Corsi Epigenetic regulation of the molecular clockwork Prog. Mol. Biol. Transl. Sci. 119 2013 29 50
44. S. Sahar, and P. Sassone-Corsi The epigenetic language of circadian clocks Handb. Exp. Pharmacol. 2013 29 44
45. M. Doi, J. Hirayama, and P. Sassone-Corsi Circadian regulator CLOCK is a histone acetyltransferase Cell 125 2006 497 508
46. G. Asher et al. SIRT1 regulates circadian clock gene expression through PER2 deacetylation Cell 134 2008 317 328
47. Y. Nakahata, M. Kaluzova, B. Grimaldi, S. Sahar, J. Hirayama, D. Chen, L.P. Guarente, and P. Sassone-Corsi The NAD+-dependent deacetylase SIRT1 modulates CLOCK-mediated chromatin remodeling and circadian control Cell 134 2008 329 340
48. J.S. O'Neill, E.S. Maywood, J.E. Chesham, J.S. Takahashi, and M.H. Hastings CAMP-dependent signaling as a core component of the mammalian circadian pacemaker Science 320 2008 949 953
49. M.R. Ralph, and M. Menaker A mutation of the circadian system in golden hamsters Science 241 1988 1225 1227
50. T. Hirota, W.G. Lewis, A.C. Liu, J.W. Lee, P.G. Schultz, and S.A. Kay A chemical biology approach reveals period shortening of the mammalian circadian clock by specific inhibition of GSK-3beta Proc. Natl. Acad. Sci. USA 105 2008 20746 20751
51. K. Vanselow et al. Differential effects of PER2 phosphorylation: molecular basis for the human familial advanced sleep phase syndrome (FASPS) Genes Dev. 20 2006 2660 2672
52. K.M. Walton et al. Selective inhibition of casein kinase 1 epsilon minimally alters circadian clock period J. Pharmacol. Exp. Ther. 330 2009 430 439
53. Y. Tsuchiya, M. Akashi, M. Matsuda, K. Goto, Y. Miyata, K. Node, and E. Nishida Involvement of the protein kinase CK2 in the regulation of mammalian circadian rhythms Sci. Signal. 2 2009 ra26
54. K. Yagita, I. Yamanaka, S. Koinuma, Y. Shigeyoshi, and Y. Uchiyama Mini screening of kinase inhibitors affecting period-length of mammalian cellular circadian clock Acta Histochem. Cytochem. 42 2009 89 93
55. H. Yoshitane et al. JNK regulates the photic response of the mammalian circadian clock EMBO Rep. 13 2012 455 461
56. D.J. Kojetin, and T.P. Burris REV-ERB and ROR nuclear receptors as drug targets Nat. Rev. Drug Discov. 13 2014 197 216
57. D.P. Marciano, M.R. Chang, C.A. Corzo, D. Goswami, V.Q. Lam, B.D. Pascal, and P.R. Griffin The therapeutic potential of nuclear receptor modulators for treatment of metabolic disorders: PPARgamma, RORs, and Rev-erbs Cell Metab. 19 2014 193 208
58. I. Schmutz, J.A. Ripperger, S. Baeriswyl-Aebischer, and U. Albrecht The mammalian clock component PERIOD2 coordinates circadian output by interaction with nuclear receptors Genes Dev. 24 2010 345 357
59. N. Preitner, F. Damiola, L. Lopez-Molina, J. Zakany, D. Duboule, U. Albrecht, and U. Schibler The orphan nuclear receptor REV-ERBalpha controls circadian transcription within the positive limb of the mammalian circadian oscillator Cell 110 2002 251 260
60. H. Cho et al. Regulation of circadian behaviour and metabolism by REV-ERB-alpha and REV-ERB-beta Nature 485 2012 123 127
61. B. Kornmann, O. Schaad, H. Bujard, J.S. Takahashi, and U. Schibler System-driven and oscillator-dependent circadian transcription in mice with a conditionally active liver clock PLoS Biol. 5 2007 e34
62. F. Guillaumond, H. Dardente, V. Giguere, and N. Cermakian Differential control of Bmal1 circadian transcription by REV-ERB and ROR nuclear receptors J. Biol. Rhythms 20 2005 391 403
63. M.L. Privalsky The role of corepressors in transcriptional regulation by nuclear hormone receptors Annu. Rev. Physiol. 66 2004 315 360
64. K.I. Pardee et al. The structural basis of gas-responsive transcription by the human nuclear hormone receptor REV-ERBbeta PLoS Biol. 7 2009 e43
65. J.A. Kallen, J.M. Schlaeppi, F. Bitsch, S. Geisse, M. Geiser, I. Delhon, and B. Fournier X-ray structure of the hRORalpha LBD at 1.63 A: structural and functional data that cholesterol or a cholesterol derivative is the natural ligand of RORalpha Structure 10 2002 1697 1707
66. J. Kallen, J.M. Schlaeppi, F. Bitsch, I. Delhon, and B. Fournier Crystal structure of the human RORalpha Ligand binding domain in complex with cholesterol sulfate at 2.2 A J. Biol. Chem. 279 2004 14033 14038
67. D. Grant et al. GSK4112, a small molecule chemical probe for the cell biology of the nuclear heme receptor Rev-erbalpha ACS Chem. Biol. 5 2010 925 932
68. R. Noel et al. Synthesis and SAR of tetrahydroisoquinolines as Rev-erbalpha agonists Bioorg. Med. Chem. Lett. 22 2012 3739 3742
69. L.A. Solt et al. Regulation of circadian behaviour and metabolism by synthetic REV-ERB agonists Nature 485 2012 62 68
70. Y. Wang, N. Kumar, P. Nuhant, M.D. Cameron, M.A. Istrate, W.R. Roush, P.R. Griffin, and T.P. Burris Identification of SR1078, a synthetic agonist for the orphan nuclear receptors RORalpha and RORgamma ACS Chem. Biol. 5 2010 1029 1034
71. N. Gekakis, D. Staknis, H.B. Nguyen, F.C. Davis, L.D. Wilsbacher, D.P. King, J.S. Takahashi, and C.J. Weitz Role of the CLOCK protein in the mammalian circadian mechanism Science 280 1998 1564 1569
72. E.A. Griffin Jr., D. Staknis, and C.J. Weitz Light-independent role of CRY1 and CRY2 in the mammalian circadian clock Science 286 1999 768 771
73. Y. Hu et al. Selenium is a modulator of circadian clock that protects mice from the toxicity of a chemotherapeutic drug via upregulation of the core clock protein, BMAL1 Oncotarget 2 2011 1279 1290
74. S.K. Chun et al. Identification and validation of cryptochrome inhibitors that modulate the molecular circadian clock ACS Chem. Biol. 9 2014 703 710
75. V.Y. Gorbacheva, R.V. Kondratov, R. Zhang, S. Cherukuri, A.V. Gudkov, J.S. Takahashi, and M.P. Antoch Circadian sensitivity to the chemotherapeutic agent cyclophosphamide depends on the functional status of the CLOCK/BMAL1 transactivation complex Proc. Natl. Acad. Sci. USA 102 2005 3407 3412
76. D.L. Hatfield, P.A. Tsuji, B.A. Carlson, and V.N. Gladyshev Selenium and selenocysteine: roles in cancer, health, and development Trends Biochem. Sci. 39 2014 112 120
77. J.H. Lee, S. Gaddameedhi, N. Ozturk, R. Ye, and A. Sancar DNA damage-specific control of cell death by cryptochrome in p53-mutant ras-transformed cells Cancer Res. 73 2013 785 791
78. N. Ozturk, J.H. Lee, S. Gaddameedhi, and A. Sancar Loss of cryptochrome reduces cancer risk in p53 mutant mice Proc. Natl. Acad. Sci. USA 106 2009 2841 2846
79. G. Aad et al. Search for dilepton resonances in pp collisions at radicals = 7 TeV with the ATLAS detector Phys. Rev. Lett. 107 2011 272002
80. A. Relogio et al. Ras-mediated deregulation of the circadian clock in cancer PLoS Genet. 10 2014 e1004338
81. J.A. Mohawk, C.B. Green, and J.S. Takahashi Central and peripheral circadian clocks in mammals Annu. Rev. Neurosci. 35 2012 445 462
82. S.H. Yoo et al. A non-canonical E-box enhancer drives mouse Period2 circadian oscillations in vivo Proc. Natl. Acad. Sci. USA 102 2005 2608 2613
83. U. Abraham, A.E. Granada, P.O. Westermark, M. Heine, A. Kramer, and H. Herzel Coupling governs entrainment range of circadian clocks Mol. Syst. Biol. 6 2010 438
84. Y. Isojima et al. CKIepsilon/delta-dependent phosphorylation is a temperature-insensitive, period-determining process in the mammalian circadian clock Proc. Natl. Acad. Sci. USA 106 2009 15744 15749
85. T. Hirota et al. High-throughput chemical screen identifies a novel potent modulator of cellular circadian rhythms and reveals CKIalpha as a clock regulatory kinase PLoS Biol. 8 2010 e1000559
86. J.W. Lee et al. A small molecule modulates circadian rhythms through phosphorylation of the period protein Angew. Chem. Int. Ed. Engl. 50 2011 10608 10611
87. Z. Chen et al. Identification of diverse modulators of central and peripheral circadian clocks by high-throughput chemical screening Proc. Natl. Acad. Sci. USA 109 2012 101 106
88. T. Hirota et al. Identification of small molecule activators of cryptochrome Science 337 2012 1094 1097
89. J.P. Etchegaray et al. Casein kinase 1 delta regulates the pace of the mammalian circadian clock Mol. Cell. Biol. 29 2009 3853 3866
90. F.D. Bushman et al. Host cell factors in HIV replication: meta-analysis of genome-wide studies PLoS Pathog. 5 2009 e1000437
91. S. Lee, Y. Jang, Y.M. Lee, J. Lee, H. Lee, G.H. Kim, and J.J. Kim Rice straw-decomposing fungi and their cellulolytic and xylanolytic enzymes J. Microbiol. Biotechnol. 21 2011 1322 1329
92. W. Xing, L. Busino, T.R. Hinds, S.T. Marionni, N.H. Saifee, M.F. Bush, M. Pagano, and N. Zheng SCF(FBXL3) ubiquitin ligase targets cryptochromes at their cofactor pocket Nature 496 2013 64 68
93. S. Nangle, W. Xing, and N. Zheng Crystal structure of mammalian cryptochrome in complex with a small molecule competitor of its ubiquitin ligase Cell Res. 23 2013 1417 1419
94. N. Huang et al. Crystal structure of the heterodimeric CLOCK:BMAL1 transcriptional activator complex Science 337 2012 189 194
95. A. Czarna, A. Berndt, H.R. Singh, A. Grudziecki, A.G. Ladurner, G. Timinszky, A. Kramer, and E. Wolf Structures of Drosophila cryptochrome and mouse cryptochrome1 provide insight into circadian function Cell 153 2013 1394 1405
96. I. Schmalen et al. Interaction of circadian clock proteins CRY1 and PER2 is modulated by zinc binding and disulfide bond formation Cell 157 2014 1203 1215
97. S.N. Nangle, C. Rosensweig, N. Koike, H. Tei, J.S. Takahashi, C.B. Green, and N. Zheng Molecular assembly of the period-cryptochrome circadian transcriptional repressor complex Elife 3 2014 e03674
98. O. Yildiz et al. Crystal structure and interactions of the PAS repeat region of the Drosophila clock protein PERIOD Mol. Cell 17 2005 69 82
99. S. Hennig, H.M. Strauss, K. Vanselow, O. Yildiz, S. Schulze, J. Arens, A. Kramer, and E. Wolf Structural and functional analyses of PAS domain interactions of the clock proteins Drosophila PERIOD and mouse PERIOD2 PLoS Biol. 7 2009 e94
100. N. Kucera et al. Unwinding the differences of the mammalian PERIOD clock proteins from crystal structure to cellular function Proc. Natl. Acad. Sci. USA 109 2012 3311 3316